Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Michael E. Hurlston sold 2,500 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $92.08, for a total transaction of $230,200.00. Following the completion of the transaction, the director now owns 91,794 shares of the company's stock, valued at approximately $8,452,391.52. This trade represents a 2.65 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Astera Labs Stock Performance
ALAB stock traded down $1.47 on Thursday, reaching $88.43. The company's stock had a trading volume of 3,857,298 shares, compared to its average volume of 5,509,518. The business has a fifty day simple moving average of $118.33 and a two-hundred day simple moving average of $84.52. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39. The firm has a market cap of $14.34 billion and a PE ratio of -51.12.
Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.76% and a negative net margin of 21.05%. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Astera Labs
A number of institutional investors have recently added to or reduced their stakes in ALAB. Whittier Trust Co. of Nevada Inc. bought a new position in Astera Labs in the fourth quarter worth $25,000. Hollencrest Capital Management bought a new position in Astera Labs in the third quarter worth $26,000. Steward Partners Investment Advisory LLC raised its holdings in Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock worth $26,000 after purchasing an additional 99 shares in the last quarter. Kestra Investment Management LLC bought a new position in shares of Astera Labs during the fourth quarter valued at $28,000. Finally, Geneos Wealth Management Inc. bought a new position in shares of Astera Labs during the fourth quarter valued at $36,000. Institutional investors own 60.47% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on ALAB shares. Morgan Stanley dropped their price objective on shares of Astera Labs from $142.00 to $114.00 and set an "equal weight" rating for the company in a report on Tuesday, January 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $140.00 price objective on shares of Astera Labs in a research report on Tuesday, February 11th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price target for the company in a research report on Tuesday, January 28th. Finally, Craig Hallum lifted their price target on shares of Astera Labs from $105.00 to $125.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $115.33.
Read Our Latest Report on Astera Labs
About Astera Labs
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.